Ronald Blue Trust, Inc. Veracyte, Inc. Transaction History
Ronald Blue Trust, Inc.
- $8.16 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 2,131 shares of VCYT stock, worth $93,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,131
Previous 2,781
23.37%
Holding current value
$93,060
Previous $94,000
10.64%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VCYT
# of Institutions
310Shares Held
81.7MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$340 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$338 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$219 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$215 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$185 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.13B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...